Pursuing Originality, Precision and Customer Orientation through MDx and Total Supply Care
We will develop innovative and precise MDx products and provide our services in a customer-oriented manner.
Pursuing Originality, Precision and Customer Orientation through MDx and Total Supply Care
We will develop innovative and precise MDx products and provide our services in a customer-oriented manner.
Pursuing Originality, Precision and Customer Orientation through MDx and Total Supply Care
We will develop innovative and precise MDx products and provide our services in a customer-oriented manner.
Pursuing Originality, Precision and Customer Orientation through MDx and Total Supply Care
We will develop innovative and precise MDx products and provide our services in a customer oriented manner.
CORE VALUE
Realize prompt and accurate molecular diagnostics and support early-stage diagnosis and timely personalized medicine.
We are developing nucleic acid preparation and MDx and CDx technology targeting various infectious diseases and genetic disorders including COVID-19, mycobacterium tuberculosis, fungal diseases, Orientia tsutsugamushi and liquid biopsy from cancers.
EXPERTISE
Focus on developing products that exhibit optimal performance in the MDx market.
HORIZONTAL
Pursue efficient cooperation in a horizontal company culture and releasing a wide range of MDx products.
ORIGINALITY
Encourage creative thinking and put our efforts on developing innovative products.
\
We are focused on developing innovative technology that could continuously contribute to medical diagnosis even in the circumstances of rapidly changing IVD market.
Our development goal is to realize prompt and accurate MDx even when there are low quantity of pathogens from various diseases.
CORE VALUE
Realize prompt and accurate molecular diagnostics and support early-stage diagnosis and timely personalized medicine.
We are developing nucleic acid preparation and MDx and CDx technology targeting various infectious diseases and genetic disorders including COVID-19, mycobacterium tuberculosis, fungal diseases, Orientia tsutsugamushi and liquid biopsy from cancers.
EXPERTISE
We focus on developing products that exhibit optimal performance in the MDx market.
HORIZONTAL
We pursue efficient cooperation in a horizontal company culture and releasing a wide range of MDx products.
ORIGINALITY
We encourage creative thinking and put our efforts on developing innovative products.
We are focused on developing innovative technology that could continuously contribute to medical diagnosis even in the circumstances of rapidly changing IVD market.
Our development goal is to realize prompt and accurate MDx even when there are low quantity of pathogens from various diseases.
INFUSIONTECH, Inc.ㅣ CEO : Nam Heon, Kim ㅣ Company Registration Number : 492-87-01515 Tel: +82-31-687-3459 ㅣFAX : +82-31-624-1518 ㅣ E-Mail: infusion@infusiontech.co.kr
#1202, 38, Heungan-daero 427 beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Korea